联合生育力保存方案的多重保障可行性研究
该回顾性观察研究纳入2012至2018年207例接受医学生育力保存的女性患者,分析卵巢刺激、IVM与卵巢组织冷冻等单独或联合方案的可行性。在随访中31例尝试妊娠,新鲜卵母细胞ART后9例活产,冻存材料复苏后8例活产,提示联合方案可行且生殖结局有望。
要点
- 对特定患者,联合不同生育力保存方案是可行策略。
- 31例返院妊娠者中新鲜卵ART活产9例,冻存材料复苏活产8例。
核心结论
- 在选定患者中联合不同生育力保存方案是可行方法,返院尝试妊娠者的生殖结局有望。
研究设计与样本
- 大学附属三级生育中心的回顾性观察研究,纳入2012年1月至2018年12月所有接受紧急医学生育力保存的女性患者207例。
- 对单独或联合的各种生育力保存方案进行描述性分析,并记录随访期尝试妊娠者的生殖结局。
主要发现
- 207例中乳腺癌95/207(46%),血液系统恶性肿瘤43/207(21%),妇科肿瘤31/207(15%),平均年龄27.0±8.3岁。
- 17例(8.2%)经阴道取卵行IVM,获9.2±10.1枚MII卵母细胞。
- 17例(8.2%)行OTC联合OTO-IVM及对侧卵巢经阴道取卵IVM,获13.5±9.7枚MII卵母细胞;13例(6.3%)行OTC联合OTO-IVM后对侧卵巢控制性刺激,共获11.3±6.6枚MII卵母细胞。
临床怎么用
- 对需紧急生育力保存的患者,可经多学科讨论制定个体化策略,在可行时联合多种方案冻存不同来源的生殖组织。
局限性
- 该生育力保存方案基于个体化策略而非效率驱动的算法。
- 数据为描述性,无法得出确定性结论。
- 联合方案可能改善接受性腺毒性治疗患者的生殖潜能,但需进一步随访研究确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What is the reproductive potential following combinations of ovarian stimulation, IVM and ovarian tissue cryopreservation (OTC) in female patients seeking fertility preservation (FP)? SUMMARY ANSWER: In selected patients, combining different FP procedures is a feasible approach and reproductive outcomes after FP in patients who return to attempt pregnancy are promising. WHAT IS KNOWN ALREADY: FP is increasingly performed in fertility clinics but an algorithm to select the most suitable FP procedure according to patient characteristics and available timeframe is currently lacking. Vitrification of mature oocytes (OV) and OTC are most commonly performed, although in some clinical scenarios a combination of procedures including IVM, to spread the sources of gametes, may be considered in order to enhance reproductive options for the future. STUDY DESIGN, SIZE, DURATION: Retrospective, observational study in a university-based, tertiary fertility centre involving all female patients who underwent urgent medical FP between January 2012 and December 2018. Descriptive analysis of various FP procedures, either stand-alone or combined, was performed, and reproductive outcomes of patients who attempted pregnancy in the follow-up period were recorded. PARTICIPANTS/MATERIALS, SETTING, METHODS: In total, 207 patients underwent medical FP. Patient-tailored strategies and procedures were selected after multidisciplinary discussion. When deemed feasible, FP procedures were combined to cryopreserve different types of reproductive tissue for future use. The main primary outcome measure was the number of mature oocytes. Live birth rates were evaluated in patients who returned for reproductive treatment. MAIN RESULTS AND THE ROLE OF CHANCE: Among patients seeking FP, 95/207 (46%) had breast cancer, 43/207 (21%) had haematological malignancies and 31/207 (15%) had a gynaecological tumour. Mean ± SD age was 27.0 ± 8.3 years. Eighty-five (41.1%) patients underwent controlled ovarian stimulation (COS), resulting in 10.8 ± 7.1 metaphase II (MII) oocytes for vitrification. Eleven (5.3%) patients had multiple COS cycles. Transvaginal oocyte retrieval for IVM was performed in 17 (8.2%) patients, yielding 9.2 ± 10.1 MII oocytes. Thirty-four (16.4%) patients underwent OTC combined with IVM of oocytes retrieved from ovarian tissue 'ex vivo' (OTO-IVM), yielding 4.0 ± 4.3 MII oocytes in addition to ovarian fragments. Seventeen (8.2%) patients had OTC combined with OTO-IVM and transvaginal retrieval of oocytes for IVM from the contralateral ovary, resulting in 13.5 ± 9.7 MII oocytes. In 13 (6.3%) patients, OTC with OTO-IVM was followed by controlled stimulation of the contralateral ovary, yielding 11.3 ± 6.6 MII oocytes in total. During the timeframe of the study, 31/207 (15%) patients have returned to the fertility clinic with a desire for pregnancy. Of those, 12 (38.7%) patients had preserved ovarian function and underwent ART treatment with fresh oocytes, resulting in nine (75%) livebirth. The remaining 19 (61.3%) patients requested warming of their cryopreserved material because of ovarian insufficiency. Of those, eight (42.1%) patients had a livebirth, of whom three after OTO-IVM. To date, 5/207 patients (2.4%) achieved an ongoing pregnancy or livebirth after spontaneous conception. LIMITATIONS, REASONS FOR CAUTION: Our FP programme is based on a patient-tailored approach rather than based on an efficiency-driven algorithm. The data presented are descriptive, which precludes firm conclusions. WIDER IMPLICATIONS OF THE FINDINGS: Combining different FP procedures is likely to enhance the reproductive fitness of patients undergoing gonadotoxic treatment but further follow-up studies are needed to confirm this. STUDY FUNDING/COMPETING INTEREST(S): No external funding was used for this study and the authors have no competing interests. TRIAL REGISTRATION NUMBER: N/A.
引用
- Delattre S, Segers I, Van Moer E, et al. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study. Hum Reprod. 2020. PMID: 32951035. doi:10.1093/humrep/deaa193
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。